Menu
Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1
The physiology of cardiovascular disease and innovative liposomal platforms for therapy
Authors Ruiz-Esparza G, Flores-Arredondo J, Segura-Ibarra V, Torre-Amione G, Ferrari M, Blanco E, Serda R
Received 1 October 2012
Accepted for publication 6 November 2012
Published 9 February 2013 Volume 2013:8(1) Pages 629—640
DOI https://doi.org/10.2147/IJN.S30599
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Guillermo U Ruiz-Esparza,1,3 Jose H Flores-Arredondo,2 Victor Segura-Ibarra,3 Guillermo Torre-Amione,2,3 Mauro Ferrari,1 Elvin Blanco,1,* Rita E Serda1,3,*
1Methodist Hospital Research Institute, 2Methodist DeBakey Heart and Vascular Center, Methodist Hospital, Houston, TX, USA; 3Escuela de Medicina y Ciencias de la Salud, Instituto Tecnológico y de Estudios Superiores de Monterrey, Cátedra de Cardiología y Medicina Vascular, Monterrey, Mexico
*Senior authors
Abstract: Heart disease remains the major cause of death in males and females, emphasizing the need for novel strategies to improve patient treatment and survival. A therapeutic approach, still in its infancy, is the development of site-specific drug-delivery systems. Nanoparticle-based delivery systems, such as liposomes, have evolved into robust platforms for site-specific delivery of therapeutics. In this review, the clinical impact of cardiovascular disease and the pathophysiology of different subsets of the disease are described. Potential pathological targets for therapy are introduced, and promising advances in nanotherapeutic cardiovascular applications involving liposomal platforms are presented.
Keywords: liposomes, cardiovascular disease, therapeutics, nanoparticles, nanomedicine
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.